{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:11:29Z","timestamp":1788635489365,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIAAMC"],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Bigel formulations are multifunctional two-phase systems that incorporate\nhydrogels and organogels in varying ratios, maximizing the functional advantages of the water and\noil phases. Such a biphasic system addresses the drawbacks of monophasic gels, in which organogels\nenhance transdermal penetration while the hydrogel maintains adequate hydration of the stratum\ncorneum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A hydrogel system was dispensed by gradually adding Carbopol 940 into distilled water\nwhile maintaining uniform stirring. For the preparation of organogels, Span 20 and Span 80 were\nincorporated into olive oil at an elevated temperature (60\u00b0C) with constant agitation. The final hydrogel\nand organogel bases were homogenized in varying proportions to obtain bigel formulations.\nThe formulation was evaluated for parameters such as spreadability, extrudability, swelling behaviour,\ndrug content, in vitro drug release profile, stability testing, and antimicrobial assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>results:<\/jats:title>\n                    <jats:p>Among all batches, formulation B5 exhibited the highest drug release (80.81% at 6 hours) and demonstrated potent antimicrobial efficacy, as reflected by a zone of inhibition ranging from 17.43 \u00b1 0.04 mm to 36.33 \u00b1 1.15 mm against microbial strains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>The formulations were comprehensively evaluated for physicochemical characteristics such\nas spreadability, extrudability, swelling behaviour, viscosity, drug content, and stability upon centrifugation.\nAmong the prepared batches, B5 showed the highest drug release (94.1% at 8 h) and displayed\nsignificant antimicrobial activity, producing zones of inhibition ranging from 17.43 \u00b1 0.04\nmm to 36.33 \u00b1 1.15 mm against the tested microbial strains. Stability studies demonstrated their\nphysicochemical properties throughout the three-month accelerated stability study, indicating robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Effective topical administration against Candida albicans was demonstrated by the optimal\nrelease, stability, and antifungal activity of B5 optimized clotrimazole bigel. With all factors\nconsidered, outcomes suggest bigel-based administration as a feasible approach for enhancing local\nclotrimazole therapy while retaining high patient acceptability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Among the prepared batches, B5 showed the largest zone of inhibition (36.33 \u00b1 1.15\nmm) against Candida albicans, demonstrating the potential of the developed bigel as an effective\ntopical treatment for cutaneous fungal infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715230482419260827074916","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:47:26Z","timestamp":1788634046000},"source":"Crossref","is-referenced-by-count":0,"title":["Development and Characterization of a Clotrimazole-loaded Bigel for Topical Drug Delivery"],"prefix":"10.2174","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2722-101X","authenticated-orcid":true,"given":"Tushar","family":"Varshney","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5484-1207","authenticated-orcid":true,"given":"Sukhdev","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9556-3583","authenticated-orcid":true,"given":"Vibha","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6131-5702","authenticated-orcid":true,"given":"Manu","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-7610","authenticated-orcid":true,"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology,  Rajiv Academy for Pharmacy, Mathura (U.P.), India, Kashi Institute of Pharmacy, MS 23KM, Varanasi \u2013 Prayagraj (Allahabad) Highway, Mirzamurad, Varanasi, Uttar Pradesh, 221307, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Anti-Inflammatory &amp; Anti-Allergy Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715230482419260827074916","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258048\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715230482419260827074916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:47:39Z","timestamp":1788634059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258048\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715230482419260827074916","relation":{},"ISSN":["1871-5230"],"issn-type":[{"value":"1871-5230","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}